Damora Therapeutics, Inc. (DMRA) Insider Trading -- Recent Executive & Director Transactions
2 insiders reported 4 Form 4 transactions for Damora Therapeutics, Inc. (DMRA) over the past 18 months (most recent 2026-09-28). Recent activity: Jarrett Jennifer (Director, President and CEO) Buy 12,500 shares, Winslow Garrett (General Counsel) Buy 680 shares, Winslow Garrett (General Counsel) Sell 245 shares, Jarrett Jennifer (President and Chief Executive Officer) Buy 500,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-28 | Jarrett Jennifer | Director, President and CEO | Buy | 12,500 | $252,875 |
| 2026-07-07 | Winslow Garrett | General Counsel | Buy | 680 | $0 |
| 2026-07-07 | Winslow Garrett | General Counsel | Sell | 245 | $7,345 |
| 2026-04-01 | Jarrett Jennifer | President and Chief Executive Officer | Buy | 500,000 | $0 |
Source: SEC Form 4 filings · as of 2026-09-28